Page last updated: 2024-09-03

gefitinib and rimcazole

gefitinib has been researched along with rimcazole in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(rimcazole)
Trials
(rimcazole)
Recent Studies (post-2010) (rimcazole)
5,2315662,919103213

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)rimcazole (IC50)
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.14
Sigma non-opioid intracellular receptor 1Cavia porcellus (domestic guinea pig)1.0235
Scavenger receptor class B member 1Homo sapiens (human)1.2
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.9196
Sigma non-opioid intracellular receptor 1Rattus norvegicus (Norway rat)1.4152

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baskaran, S; Forsberg Nilsson, K; Gerlee, P; Häggblad, M; Hansson, C; Karlsson-Lindahl, L; Kling, T; Lundgren, B; Martens, U; Monsefi, N; Nelander, S; Olsson, M; Schmidt, L; Uhrbom, L; Westermark, B1

Other Studies

1 other study(ies) available for gefitinib and rimcazole

ArticleYear
Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions.
    Neuro-oncology, 2013, Volume: 15, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Cell Line, Tumor; Drug Interactions; Gefitinib; Glioblastoma; Humans; Quinazolines; Sertraline; Stilbenes

2013